IP Library Granted Patent US 11,439,577
Granted Patent B2
US 11,439,577 · App. 16/635,199 · Granted Sep 13, 2022

Anti-aging or skin-regenerating composition comprising piperonylic acid as effective ingredient

Inventors: Kyong Tai Kim (Gyeongsangbuk-do, KR); Dohyun Lee (Gyeongsangbuk-do, KR); Jinsun Lim (Gyeongsangbuk-do, KR)
Assignee: HESED BIO CO., LTD.
A61K8/4973A23L33/10A23L33/40A61K31/36A61Q19/08A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,439,577
App. No.
16/635,199
Granted
Sep 13, 2022
Kind
B2
Abstract

The present invention relates to a pharmaceutical composition comprising piperonylic acid as an effective ingredient for anti-aging or regenerating the skin. A composition according to the present invention utilizes piperonylic acid that various plant species naturally contain therein and thus does not cause side effects. Piperonylic acid activates signals associated with cell survival, growth, and proliferation to exhibit the effect of increasing the resistance and survival of skin cells against external stimuli and enhancing the regeneration of the skin damaged due to external stimuli or senescence. In addition, piperonylic acid of the present invention has a similar function to EGF, but is stable and small in size in contrast to EGF. Thus, piperonylic acid of the present invention has the advantage of being able to easily move to the skin basal layer across the skin barrier and perform its function. Piperonylic acid of the present invention is expected to find applications in various fields including medicines, quasi-drugs, cosmetics, cosmetic substances, functional biomaterials, and functional food materials.

Claims (9)

1. A method for anti-aging or regenerating the skin, the method comprising administering a pharmaceutically effective amount of piperonylic acid to an individual.

2. The method of claim 1 , wherein the piperonylic acid alleviates or treats skin wounds.

3. The method of claim 1 , wherein the piperonylic acid alleviates or treats burn wounds.

4. The method of claim 1 , wherein the piperonylic acid promotes the proliferation or growth of cells by binding to an epidermal growth factor receptor (EGFR).

5. The method of claim 4 , wherein the cells are keratinocytes.

6. The method of claim 1 , wherein the piperonylic acid enhances resistance to cell damage due to external stimuli.

7. The method of claim 6 , wherein the external stimuli is ultraviolet rays.

8. The method of claim 1 , wherein the piperonylic acid enhances skin elasticity.

9. The method of claim 1 , wherein the piperonylic acid alleviates skin wrinkles.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2020
From: KIM, KYONG TAI; LEE, DOHYUN; LIM, JINSUN
To: HESED BIO CO., LTD.
Reel/Frame 052548/0211 →
Priority Claims (1)
KR 10-2017-0098011 · Aug 2, 2017 · national
Continuity (1)
Related Publication 20210100728A1 · Apr 8, 2021